Offer - Urjas Oil for just ₹ 1 X
Fibrolip is a prescription medicine that is available as a Capsule. High Cholesterol, High Triglycerides are some of its major therapeutic uses.
Medical history of the patient along with age and gender determines the dosage of Fibrolip. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Fibrolip as well, which are listed below. Usually, these side effects of Fibrolip go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Fibrolip's effect is Unknown during pregnancy and Unknown for lactating mothers. It is important to know if Fibrolip has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Fibrolip related warnings section.
Fibrolip is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease, Kidney Disease, Cholecystitis are examples of such conditions. Some other conditions that can be affected by Fibrolip are listed in the contraindications section below.
Additionally, Fibrolip may also adversely react with other medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Fibrolip is safe while driving, and is is addictive in nature.
Fibrolip is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Fibrolip safe for pregnant women?
No research has not been done till date on the safety of Fibrolip for pregnant women. So its effects on pregnant women are unknown.
Is the use of Fibrolip safe during breastfeeding?
In the absence of any scientific study about the side effects of Fibrolip in breastfeeding women, information on safety of Fibrolip is unavailable.
What is the effect of Fibrolip on the Kidneys?
There can be some harmful effects on your kidneys after taking Fibrolip. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Fibrolip on the Liver?
Fibrolip may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Fibrolip on the Heart?
Fibrolip can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Fibrolip should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Fibrolip unless your doctor advises you to do so -
Is this Fibrolip habit forming or addictive?
No, you will not get addicted to Fibrolip.
Is it safe to drive or operate heavy machinery when consuming?
Fibrolip will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, Fibrolip is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Fibrolip for mental disorders.
Interaction between Food and Fibrolip
Eating certain foods may increase the time it takes Fibrolip to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Fibrolip
Due to lack of research, there is no information about the side effects of taking Fibrolip with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552